Contributing critical developments
to the treatment of infectious disease.
The Infectious Diseases Clinical Outcomes Research Evaluation (ID-CORE) team at the Lundquist Institute works closely with Harbor-UCLA Medical Center in order to provide the highest quality in clinical service, promote excellence in clinical training, conduct innovative basic and applied research, and develop breakthrough approaches to meet emerging challenges in infectious diseases.
Our Current Studies
Antibiotic resistant infections are one of today’s most pressing health threats.
Learn more about our work to develop new paths for combating antibiotic resistance and improving healthcare practices to avoid the spread of MRSA (methicillin resistant Staphylococcus aureus) and other highly antibiotic-resistant bacteria.
CORGI Trial
Join a trial that aims to find new treatment options for bone and joint infections, particularly focusing on omadacycline to assess its safety, effectiveness, and tolerability in treating antibiotic-resistant germs causing these infections. This study is enrolling adults with current bone and joint infection.
TODOS Trial
Join a trial that aims compare the efficacy and safety of doxycycline and trimethoprim/sulfamethoxazole in treating skin infections. This study is enrolling adults with current skin infections.
Our Facility
The Lundquist Institute for Biomedical Innovation is a 501(c)3 independent non-profit biomedical research organization that was founded in 1952. The Institute has over more than 120 principal investigators and 400 researchers in total — MD’s, MD/Ph.D.’s, and Ph.D.’s — working on over 1,000 research studies. We are academically affiliated with the David Geffen School of Medicine at UCLA and work in partnership with the Harbor-UCLA Medical Center. Our research is funded by many sources including grants from the NIH and other government entities, Industry and teaching contracts and royalties, as well as private donors and other non-profit foundations.
Harbor-UCLA Medical Center began as the station hospital at the Los Angeles Port of Embarkation. In 1951, Harbor General Hospital affiliated with the University of California as a teaching hospital for the UCLA School of Medicine. Following the passage of a bond issue in the mid 1950’s, a new eight story replacement facility opened in 1963. Over the years the hospital and medical programs of the facility have grown and improved steadily.
Our team is comprised of caring physicians, pharmacists, and researchers with extensive experience in translating knowledge to the patient bedside, developing new treatments, and improving patient care.
Contact Us
Reach out to our team for more information on our current and upcoming studies.
Email us at IDCORE@Lundquist.org
© 2023 ID CORE at The Lundquist Institute For Biomedical Innovation at Harbor-UCLA Medical Center